Clinical Trials
5 trialsNCT04915183 2026-06-05
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT07407582 2026-06-05
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
University of Arizona
Phase 1/2 Recruiting
NCT06781749 2026-05-11
New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss
University of Southern California
Recruiting
NCT07218913 2026-04-17
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
City of Hope Medical Center
Phase 1 Recruiting
NCT06517888 2026-04-06
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Akouos, Inc.
Phase 1/2 Recruiting